Biomarker predicts response to TNF blockers
A new assay that accurately measures how arthritis patients respond to treatment with TNFalpha blockers such as adalimumab, open up the way to predict efficacy.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1185 entries already.
Entries by Thomas Gabrielczyk
UK launches new payment model for antimicrobials
/in News/by Thomas GabrielczykIn order to incentivise drug companies to re-enter development of antibiotics, the UK government announced it will establish a licence model to assure developers sufficient return on investments (ROI).
BioNtech swallows MAB Discovery antibody unit
/in News/by Thomas GabrielczykImmunoncology and vaccine specialist BioNTech AG is broadening its antibody discovery capabilities by acquiring MAB Discoverys antibody generation unit.
Clariant inks cellulosic biodiesel pact with ExxonMobil/REG
/in News/by Thomas GabrielczykSwiss fine chemicals specialist Clariant has hammered out a R&D pact with ExxonMobil and Renewable Energy Group (REG) Inc to combine technologies in order of producing biodiesel from cellulose
IMI launches 80m call
/in News/by Thomas GabrielczykThe Innovative Medicines Initiative II has earmarked 80m for pre-competetive research improving the pharmaceutical industry’s productivity.
AMR: Novo Holdings funds companies with 18m
/in News/by Thomas GabrielczykNovo Holdings has invested 18m from its 135m REPAIR Impact Fund into four companies.
Boehringer expands neurology activities
/in News/by Thomas GabrielczykBoehringer Ingelheim has expanded its 2014 R&D collaboration with the BioMed X Innovation Center (Heidelberg, Germany) to find new treatment approaches for early intervention of psychiatric diseases.
New target for lung fibrosis discovered
/in News/by Thomas GabrielczykCanadian and Finnish researchers have demonstrated that long immune cell contact to lung tissue turns tissue repair into fibrosis.
Valneva inks $59m JE vaccine supply contract
/in News/by Thomas GabrielczykFrench vaccine specialist Valneva SE has inked a supply contract with the US Department of Defense for IXIARO its Japanese encephalitis (JE).
VTT turn waste into biofuels and chemicals
/in News/by Thomas GabrielczykResearchers at VTT Technical Research Centre of Finland Ltd have presented a new gasification-based technique to turn forest industry byproducts into transport fuels and chemicals.